Explore News
-
1 in 3 Pregnant Women with Poor Sleep Develop Gestational Diabetes
New research from Finland identifies disrupted sleep during pregnancy as a critical predictor of gestational…
-
New Oral Delivery Method Boosts GLP-1 Drug Efficacy by 80%
A novel delivery system from Duke University allows patients to take GLP-1 medications orally with…
-
1.5 Million NHS Patients Gain Equal Diabetes Access
The NHS rollout of hybrid closed-loop systems has significantly improved access to advanced diabetes technology…
-
Why a Modified Mediterranean Diet Prevents Type 2 Diabetes
A landmark European trial demonstrates that a calorie-controlled Mediterranean diet, combined with physical activity and
-
Oral Microbiome Reveals Surprising Links to Metabolic Disease
A groundbreaking study uncovers strong associations between the bacteria in your mouth and conditions like…
-
Ozempic Cuts Blood Pressure by 5 Points in New Study
A growing body of evidence suggests that GLP-1 receptor agonists, originally developed for type 2…
-
How a Quintuple-Receptor Drug Could Revolutionize Obesity and Diabetes Treatment
A newly corrected study in Nature reveals a multi-target drug compound that simultaneously activates five…
-
1 in 3 Partners Affected by Chronic Illness After GD Diagnosis
New research shows that gestational diabetes in women may be a marker for broader family…
-
1 in 5 Diabetics Has Undetected Dental Infections
Chronic dental infections may trigger systemic inflammation that impairs glucose metabolism, new research suggests, with
-
GLP-1 Drugs May Cut Breast Cancer Recurrence Risk by 38%
A landmark study reveals that diabetes and obesity drugs like Ozempic may significantly improve survival…
